PMDA drug package insert
タブネオスカプセル10mg
PMDA Prescription drug · キッセイ薬品工業株式会社 · package insert Jul 3, 2026
Key facts
| Brand names | タブネオスカプセル10mg |
|---|---|
| Nonproprietary names | アバコパン |
| Companies | 製造販売元／キッセイ薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的C5a受容体拮抗薬 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999056M1026 |
| Approval numbers | 30300AMX00453000 |
| Package insert edition | 第7版 |
| Package insert date | Jul 3, 2026 |
| PMDA document key | 230034_3999056M1026_1 |
| PMDA company code | 230034 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: